Degrees:

PhD, MSc, Molecular Biology - Laval University

BSc, Biological Sciences - Universite Paris V

Development: 

• Emotional Intelligence

• Situational Leadership

• Change Management

• Finance

• OKRs, KPIs

• Principles of Ownership, Control, Access, and Possession (OCAP®)

Languages:

• Fluent in English, French, and Portuguese

Executive Operations:

• Profit & Loss Accountability

• Audit Oversight

• Financial Operations

• Human Resources, Belonging and Performance Culture Stewardship

• Governance, Risk & Compliance

• Data Stewardship

• Program Strategy & Implementation

• Legal & Contract Oversight

• Go-to-Market Strategy Support

• Strategic Communication & Marketing Enablement​

​

Research & Development (R&D):

• Program Design & Delivery

• Partnership Development

• Clinical Trial Oversight (Phases I–III)

• Community Research

• Good Clinical Practices (GCP) and Pharmacovigilance

• Prototype Development, Efficacy and Safety Product Validation at Accredited Testing Laboratories (GMP/GLP-Compliant, BSL-2/3) under ASTM, ASHRAE, ISO, UL, and Nemko Standards

• Scientific & Technical Due Diligence

• Technology Sourcing & Evaluation

• Health Product Software-as-a-Service (SaaS) & Dashboard Development

• Peer-Reviewed Publications

• Logic Models, Summative/Formative Program Evaluations

Market Experience:​

• Growth Stages: Pre-Seed, Series A–C, Post-IPO

• Primary Markets: Canada, United States

• Secondary Markets: United Kingdom, Germany, Australia​

​

Investment Oversight:​

• $5-15 M Portfolios

• Scientific Due-Diligence, Mergers & Acquisition Support

• Strategic and Targeted Investments ​in Research, Technology, and Capacity Building

​

Domains and Partnerships:

• Local, Provincial, Territorial, and Federal Government Agencies 

• Indigenous Governments and Organizations

• Medium to Large Universities, Schools

• Startups and Scaleups

• Non-Profit, Charitable, and Community-Based, and Sports Promotion Organizations

• ​Molecular Biology Across Diverse Fields, Including Genetics, Neuroscience, Microbiology, Public Health, and Emerging Areas (Photonics) at the Intersection With Physics and Engineering.

​​​​

Regulatory:

• Health Canada's Therapeutic Products Directorate (TPD), Natural and Non-prescription Health Products Directorate (NNHPD), Controlled Substances and CNS Branch, Veterinary Drugs Directorate (VDD), Pest Management Regulatory Agency and Associated Guidance Documents/Acts

• U.S. Food and Drug Administration (FDA) Investigational New Drug (IND) and Investigational Device Exemption (IDE) Regulations

• Environmental Protection Agency’s (EPA) Office of Enforcement and Compliance Assurance (OECA), Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA)

• Canada Revenue Agency's Charities Directorate​

• Treasury Board Budget Submissions

Chief Operating Officer - One Yukon Coalition

2023 - Present (Calgary)

• ​Led organizational growth and One Health innovation across Northern Canada with full P&L responsibility, overseeing strategy, operations, governance, partnerships, and program delivery.

• Built a high-performing team, secured charitable status, established national and international collaborations, and expanded evidence-generation programs spanning environmental monitoring, respiratory viruses, toxic drugs, and community-based diagnostic technologies.

Director, Clinical Science - R-Zero

2021 - 2023 (Salt Lake City, USA)

• Led R-Zero’s scientific programming with Mayo Clinic, Harvard, and Columbia University partners, integrating light and sensor technologies to advance infection prevention in public settings. 

• Directed new product validation, launched the Salt Lake City R&D lab, and supported Series C funding and major enterprise sales.

​

Director, Clinical Research - CleanSlate

2020 - 2021 (Toronto)

• Positioned CleanSlate's scientific division as a market leader in SARS-CoV-2 efficacy research, testing, and product validation. 

• Launched the company’s microbiology laboratory in Toronto and led a team of biologists and engineers through Health Canada registration, securing approval under the updated PCPA framework.

​

Director, Clinical Science - Aurora

2019 - 2020 (Edmonton)

• ​Directed global clinical studies on novel treatments for epilepsy and pain, including a high-visibility partnership with the Ultimate Fighting Championship (UFC).

​

Team Lead, Project and Initiatives - Canadian Institutes of Health Research Institute of Neurosciences, Mental Health, and Addiction

2017 - 2018 (Calgary)

• ​Allocated targeted Treasury Board investments to support public safety personnel, contributing to strategic planning, advisory board formation, program evaluation, and transparent public reporting.

​

Manager - Industry and Technology Initiatives - Alberta Innovates

2015 - 2017 (Edmonton)

• ​Led province-wide research and capacity-building investments, overseeing peer review, fund allocation, and reporting.

• Guided the team through an organizational merger while ensuring strategic alignment and program continuity.

​

Postdoctoral Fellow - University of Toronto, and University of Calgary

2011 - 2015 (Calgary)

• Contributed to international research identifying a genetic link between cataracts and Alzheimer’s disease, advancing understanding of neurodegenerative conditions ​​​​​​

​

Current Committees:

• Community Member (Second Term), Health Canada Science Advisory Committee on Pest Control Products

• Ad hoc Member, Canadian Public Health Laboratory Network (CPHLN) - Data Governance & Reporting, and Surveillance Strategy & Pathogen Prioritization Task Forces

• Board Member, Mindelio/Heros Biotech™